36 related articles for article (PubMed ID: 15830006)
1. CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Leukemia; 2005 Jun; 19(6):1099-101. PubMed ID: 15830006
[No Abstract] [Full Text] [Related]
2. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
4. A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/leukemia.
dos Santos NR; Ghysdael J
Leukemia; 2006 Jan; 20(1):182-5. PubMed ID: 16281066
[No Abstract] [Full Text] [Related]
5. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
Knapp W; Strobl H; Majdic O
Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
[TBL] [Abstract][Full Text] [Related]
7. CD79b expression in B-cell chronic lymphocytic leukemia.
D'Arena G; Cascavilla N; Musto P; Colella Bisogno R; Pistolese G; Carotenuto M
Haematologica; 2000 May; 85(5):556-7. PubMed ID: 10800181
[No Abstract] [Full Text] [Related]
8. Cross-linking of B cell receptor-related MB-1 molecule induces protein tyrosine phosphorylation in early B lineage cells.
Matsuo T; Nomura J; Kuwahara K; Igarashi H; Inui S; Hamaguchi M; Kimoto M; Sakaguchi N
J Immunol; 1993 May; 150(9):3766-75. PubMed ID: 8473731
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
10. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
[TBL] [Abstract][Full Text] [Related]
11. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies.
Kedar R; Sabag O; Licthenstein M; Lorberboum-Galski H
Cancer; 2012 Dec; 118(24):6089-104. PubMed ID: 22692727
[TBL] [Abstract][Full Text] [Related]
13. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
14. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
Astsaturov IA; Matutes E; Morilla R; Seon BK; Mason DY; Farahat N; Catovsky D
Leukemia; 1996 May; 10(5):769-73. PubMed ID: 8656670
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
17. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.
Lagresle C; Bella C; Daniel PT; Krammer PH; Defrance T
J Immunol; 1995 Jun; 154(11):5746-56. PubMed ID: 7538529
[TBL] [Abstract][Full Text] [Related]
18. Retention and defective assembly of the B-cell receptor in the endoplasmic reticulum of chronic lymphocytic leukaemia B cells cannot be reverted upon CD40 ligand stimulation.
Payelle-Brogard B; Magnac C; Oppezzo P; Dumas G; Dighiero G; Vuillier F
Leukemia; 2003 Jun; 17(6):1196-9. PubMed ID: 12764393
[No Abstract] [Full Text] [Related]
19. Activation of autologous lymphocytes of patients with chronic myelogenous leukemia in the chronic phase with cytokines and CD3 monoclonal antibody results in bcr/abl- blood leukocyte cultures as determined by reverse transcriptase-polymerase chain reaction.
Krackhardt A; Maurer J; Thiel E; Notter M
Exp Hematol; 1998 Dec; 26(13):1265-70. PubMed ID: 9845383
[TBL] [Abstract][Full Text] [Related]
20. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.
Rosati E; Sabatini R; Tabilio A; Di Ianni M; Bartoli A; Marconi P
Leuk Res; 2005 Jul; 29(7):829-39. PubMed ID: 15927678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
